# A Study on Pharmacokinetics and Safety of BAT2506 Injection Versus Simponi®

> **NCT05332730** · PHASE1 · COMPLETED · sponsor: **Bio-Thera Solutions** · enrollment: 375 (actual)

## Conditions studied

- Psoriatic Arthritis

## Interventions

- **DRUG:** BAT2506 injection
- **DRUG:** Simponi® (EU commercially available product)
- **DRUG:** Simponi® (US commercially available product)

## Key facts

- **NCT ID:** NCT05332730
- **Lead sponsor:** Bio-Thera Solutions
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-08-01
- **Primary completion:** 2023-06-27
- **Final completion:** 2023-07-10
- **Target enrollment:** 375 (ACTUAL)
- **Last updated:** 2023-08-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05332730

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05332730, "A Study on Pharmacokinetics and Safety of BAT2506 Injection Versus Simponi®". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05332730. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*